Grant: CIHR Fellowship
Direct Payment
$50,000.00
The Wnt Pathway as a Modulator of Tolerogenic APCs in MS
EF 2013-14
Résumé
Antigen-presenting cells (APCs) account for a significant proportion of the cells found within lesions of multiple sclerosis (MS) and its animal model, experimental allergic encephalomyelitis (EAE). These APCs have the ability to capture myelin debris and to promote either an inflammatory response or a tolerogenic response from the effector lymphocytes. I intend to understand the molecular mechanisms which govern the switch between these two opposite types of immune responses.
This project will focus on the Wnt signalling pathway since previous studies have shown that activation of this pathway in APCs could lead to reduced inflammation in the gut. I will first demonstrate that brain infiltrating APCs express Wnt receptors. Secondly, I will demonstrate that activation of this pathway on APCs leads to an anti-inflammatory profile from the APCs, which induces a tolerogenic response from effector lymphocytes. Finally, I will demonstrate that activation of the Wnt pathway in APCs leads to reduced EAE disease.
This study aims to demonstrate that activation of the Wnt pathway on APCs favors the induction of an anti-inflammatory response, and will help in the design of new therapies for the treatment of autoimmune diseases, such as MS.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Illinois, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
301321
Name
Ifergan Igal
Region
Illinois
Country
United States of America
Orgtype
Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
The Wnt Pathway as a Modulator of Tolerogenic APCs in MS
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$50,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Antigen Presentation; Dendritic Cells; Experimental Autoimmune Encephalomyelitis; Lymphocytes; Macrophages; Monocytes; Multiple Sclerosis; Tolerization; Wnt Pathway
Abstract
Antigen-presenting cells (APCs) account for a significant proportion of the cells found within lesions of multiple sclerosis (MS) and its animal model, experimental allergic encephalomyelitis (EAE). These APCs have the ability to capture myelin debris and to promote either an inflammatory response or a tolerogenic response from the effector lymphocytes. I intend to understand the molecular mechanisms which govern the switch between these two opposite types of immune responses.
This project will focus on the Wnt signalling pathway since previous studies have shown that activation of this pathway in APCs could lead to reduced inflammation in the gut. I will first demonstrate that brain infiltrating APCs express Wnt receptors. Secondly, I will demonstrate that activation of this pathway on APCs leads to an anti-inflammatory profile from the APCs, which induces a tolerogenic response from effector lymphocytes. Finally, I will demonstrate that activation of the Wnt pathway in APCs leads to reduced EAE disease.
This study aims to demonstrate that activation of the Wnt pathway on APCs favors the induction of an anti-inflammatory response, and will help in the design of new therapies for the treatment of autoimmune diseases, such as MS.
Competitiondate
201311
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ifergan, Igal
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $50,000~ $0~